This content is machine translated Interventional valve therapy Gender differences Current evidence on gender differences in interventional valve therapy indicates that the patient pathway of aortic valve stenosis requires awareness regarding symptomatology, diagnosis, prosthesis selection, and life-time management in women.… CME-Test
View Post 3 min This content is machine translated INOCA phenomenon and co. Late-Breaking News Highlights Despite the pandemic, the American College of Cardiology’s annual meeting, while not on-site in Chicago, still scored virtually. Numerous new findings with regard to both intervention strategies and pharmacological therapies…
View Post 7 min This content is machine translated Aortic valve replacement The most frequent arrhythmias after AKE or TAVI Narrowing of the aortic valve is the most common acquired valve defect and is corrected by AKE or TAVI. However, despite advances in therapy, rhythm problems often occur. What to…
View Post 10 min This content is machine translated Infectious diseases Epidemiologic challenges in prosthetic valve endocarditis. Medical advances have also had an impact on the epidemiology of infective endocarditis. Especially catheter valve implantations (TAVI) will be a major challenge in the future.
View Post 2 min This content is machine translated Convincing results of TAVI studies New in the therapy of aortic valve stenosis Something is happening in the field of aortic valve stenosis therapy. The previous gold standard seems to be defeated by the results of transvascular aortic valve implantation.
View Post 8 min This content is machine translated Multivalvular heart disease Aortic Stenosis and Mitral Valve Regurgitation – Diagnosis and Therapy Multivalvular heart disease is a common condition whose incidence will continue to increase as a result of demographic change. A combination of aortic stenosis and mitral regurgitation is most common.…
View Post 8 min This content is machine translated Aortic valve replacement Risk stratification and effective surgery outcomes. Patients with biologic valve replacements have a higher likelihood of reoperation but a smaller likelihood of major bleeding compared with patients with mechanical aortic valve prostheses. Current studies show no…
View Post 3 min This content is machine translated PARTNER II study Data after one year are very promising At the TCT (Transcatheter Cardiovascular Therapeutics) meeting in San Francisco, 1-year data from the PARTNER II trial were presented. Transcatheter aortic valve implantation (TAVI) shows excellent results in high-risk and…
View Post 3 min This content is machine translated Transcatheter Aortic Valve Implantation (TAVI) 1-year results of the SAPIEN 3 study At EuroPCR, the Congress of Interventional Medicine, held in Paris in May 2015, the latest results of various studies on TAVI (transcatheter aortic valve implantation) were presented, among other topics.…
View Post 3 min This content is machine translated Transcatheter Aortic Valve Implantation (TAVI) PARTNER study shows survival benefit even after five years In September 2014, the Transcatheter Cardiovascular Therapeutics Conference was held in Washington, D.C., USA. Dr. Samir Kapadia, Cleveland Clinic, USA, presented the 5-year results of the PARTNER study on behalf…
View Post 7 min This content is machine translated Follow-up after heart surgery and intervention Which valve needs to be anticoagulated and how? There is clear evidence for oral anticoagulation in mechanical valves. However, individual adjustments of the target INR are sometimes necessary. Moreover, additional platelet inhibition to OAK is becoming routine. The…
